US 7534889
5-HT4 receptor agonist compounds
granted A61PA61P1/00A61P1/10
Quick answer
US patent 7534889 (5-HT4 receptor agonist compounds) held by Theravance, Inc. expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/00, A61P1/10, A61P1/14, A61P25/00